References
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1-2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Agrahari, A. K., Muskan, M., George Priya Doss, C., Siva, R., & Zayed, H. (2018). Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: A molecular modeling and dynamics approach. Metabolic Brain Disease, 33(5), 1443–1457. https://doi.org/https://doi.org/10.1007/s11011-018-0251-1
- Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins, 17(4), 412–425. https://doi.org/https://doi.org/10.1002/prot.340170408
- Aran, V., & Omerovic, J. (2019). Current approaches in NSCLC Targeting K-RAS and EGFR. International Journal of Molecular Sciences, 20(22), 5701. https://doi.org/https://doi.org/10.3390/ijms20225701
- Banerjee, A., Jang, H., Nussinov, R., & Gaponenko, V. (2016). The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. Current Opinion in Structural Biology, 36, 10–17. https://doi.org/https://doi.org/10.1016/j.sbi.2015.11.010
- Bar-Sagi, D., & Hall, A. (2000). Ras and Rho GTPases: A family reunion. Cell, 103(2), 227–238. https://doi.org/https://doi.org/10.1016/S0092-8674(00)00115-X
- Berendsen, H. J., & Hayward, S. (2000). Collective protein dynamics in relation to function. Current Opinion in Structural Biology, 10(2), 165–169. https://doi.org/https://doi.org/10.1016/S0959-440X(00)00061-0
- Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018). Kinase-targeted cancer therapies: Progress, challenges and future directions. Molecular Cancer, 17(1), 48.https://doi.org/https://doi.org/10.1186/s12943-018-0804-2
- Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., & Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res, 42(Web Server issue), W252–W258. https://doi.org/https://doi.org/10.1093/nar/gku340
- Bjelkmar, P., Larsson, P., Cuendet, M. A., Hess, B., & Lindahl, E. (2010). Implementation of the CHARMM force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. Journal of Chemical Theory and Computation, 6(2), 459–466. https://doi.org/https://doi.org/10.1021/ct900549r
- Bloom, J. D., Wilke, C. O., Arnold, F. H., & Adami, C. (2004). Stability and the evolvability of function in a model protein. Biophysical Journal, 86(5), 2758–2764. https://doi.org/https://doi.org/10.1016/S0006-3495(04)74329-5
- Bourne, H. R., Sanders, D. A., & McCormick, F. (1991). The GTPase superfamily: Conserved structure and molecular mechanism. Nature, 349(6305), 117–127. https://doi.org/https://doi.org/10.1038/349117a0
- Bryngelson, J. D., Onuchic, J. N., Socci, N. D., & Wolynes, P. G. (1995). Funnels, pathways, and the energy landscape of protein folding: A synthesis. Proteins, 21(3), 167–195. https://doi.org/https://doi.org/10.1002/prot.340210302
- Burley, S. K., Berman, H. M., Bhikadiya, C., Bi, C., Chen, L., Di Costanzo, L., Christie, C., Dalenberg, K., Duarte, J. M., Dutta, S., Feng, Z., Ghosh, S., Goodsell, D. S., Green, R. K., Guranovic, V., Guzenko, D., Hudson, B. P., Kalro, T., Liang, Y., … Zardecki, C. (2019). RCSB Protein Data Bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Research, 47(D1), D464–D474. https://doi.org/https://doi.org/10.1093/nar/gky1004
- Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C. G., Koppada, N., Lanman, B. A., Werner, J., Rapaport, A. S., San Miguel, T., Ortiz, R., Osgood, T., Sun, J.-R., Zhu, X., McCarter, J. D., … Lipford, J. R. (2019). The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 575(7781), 217–223. https://doi.org/https://doi.org/10.1038/s41586-019-1694-1
- Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P., Zampino, G., Dallapiccola, B., Gelb, B. D., & Tartaglia, M. (2006). Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. American Journal of Human Genetics, 79(1), 129–135. https://doi.org/https://doi.org/10.1086/504394
- Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982). Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature, 297(5866), 479–483. https://doi.org/https://doi.org/10.1038/297479a0
- Chardin, P., Camonis, J. H., Gale, N. W., van Aelst, L., Schlessinger, J., Wigler, M. H., & Bar-Sagi, D. (1993). Human Sos1: A guanine nucleotide exchange factor for Ras that binds to GRB2. Science (New York, N.Y.), 260(5112), 1338–1343. https://doi.org/https://doi.org/10.1126/science.8493579
- Chen, C.-W., Lin, J., & Chu, Y.-W. (2013). iStable: Off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics, 14(S2):S5. https://doi.org/https://doi.org/10.1186/1471-2105-14-S2-S5
- Clark, G. J., & Der, C. J. (1993). Oncogenic Activation of Ras Proteins. In B. F. Dickey & L. Birnbaumer (Eds.), GTPases in Biology I. (pp. 259–287). Springer. https://doi.org/https://doi.org/10.1007/978-3-642-78267-1_18
- Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014). Drugging the undruggable RAS: Mission Possible? Nature Reviews. Drug Discovery, 13(11), 828–851. https://doi.org/https://doi.org/10.1038/nrd4389
- De Baets, G., Van Durme, J., Reumers, J., Maurer-Stroh, S., Vanhee, P., Dopazo, J., Schymkowitz, J., & Rousseau, F. (2012). SNPeffect 4.0: On-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Research, 40(Database issue), D935–939. (Database issue), https://doi.org/https://doi.org/10.1093/nar/gkr996
- Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982). Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proceedings of the National Academy of Sciences of the United States of America, 79(11), 3637–3640. https://doi.org/https://doi.org/10.1073/pnas.79.11.3637
- Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., Fulton, L., Fulton, R. S., Zhang, Q., Wendl, M. C., Lawrence, M. S., Larson, D. E., Chen, K., Dooling, D. J., Sabo, A., … Wilson, R. K. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455(7216), 1069–1075. https://doi.org/https://doi.org/10.1038/nature07423
- Downward, J. (2014). RAS's cloak of invincibility slips at last? Cancer Cell, 25(1), 5–6. https://doi.org/https://doi.org/10.1016/j.ccr.2013.12.016
- Efimov, A. V., & Brazhnikov, E. V. (2003). Relationship between intramolecular hydrogen bonding and solvent accessibility of side-chain donors and acceptors in proteins. FEBS Letters, 554(3), 389–393. https://doi.org/https://doi.org/10.1016/S0014-5793(03)01189-X
- Feuerstein, J., Kalbitzer, H. R., John, J., Goody, R. S., & Wittinghofer, A. (1987). Characterisation of the metal-ion–GDP complex at the active sites of transforming and nontransforming p21 proteins by observation of the 17O-Mn superhyperfine coupling and by kinetic methods. European journal of biochemistry, 162(1), 49–55. https://doi.org/https://doi.org/10.1111/j.1432-1033.1987.tb10540.x
- George Priya Doss, C., & Zayed, H. (2017). Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metabolic Brain Disease, 32(6), 2105–2118. https://doi.org/https://doi.org/10.1007/s11011-017-0090-5
- Gerlt, J. A., Kreevoy, M. M., Cleland, W. W., & Frey, P. A. (1997). Understanding enzymic catalysis: The importance of short, strong hydrogen bonds. Chemistry & Biology, 4(4), 259–267. https://doi.org/https://doi.org/10.1016/S1074-5521(97)90069-7
- Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996). Automated docking of flexible ligands: Applications of AutoDock. Journal of Molecular Recognition, 9(1), 1–5. https://doi.org/https://doi.org/10.1002/(sici)1099-1352(199601)9:1 < 1::aid-jmr241 > 3.0.co;2-6
- Gopalakrishnan, C., Kalsi, N., Jethi, S., & Purohit, R. (2015). Computational investigation of molecular mechanism and neuropathological implications in Huntington disease. Molecular and Cellular Biochemistry, 409(1-2), 1–11. https://doi.org/https://doi.org/10.1007/s11010-015-2462-7
- Grantcharova, V. P., Riddle, D. S., Santiago, J. V., & Baker, D. (1998). Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain. Nature Structural Biology, 5(8), 714–720. https://doi.org/https://doi.org/10.1038/1412
- Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989). All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57(7), 1167–1177. https://doi.org/https://doi.org/10.1016/0092-8674(89)90054-8
- Hobbs, G. A., Wittinghofer, A., & Der, C. J. (2016). Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It's Down. Cancer Cell, 29(3), 251–253. https://doi.org/https://doi.org/10.1016/j.ccell.2016.02.015
- Hubbard, R. E., & Haider, M. K. (2010). Hydrogen bonds in proteins: Role and strength. In eLS. American Cancer Society. https://doi.org/https://doi.org/10.1002/9780470015902.a0003011.pub2
- Hunter, J. C., Gurbani, D., Ficarro, S. B., Carrasco, M. A., Lim, S. M., Choi, H. G., Xie, T., Marto, J. A., Chen, Z., Gray, N. S., & Westover, K. D. (2014). In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C. Proceedings of the National Academy of Sciences of the United States of America, 111(24), 8895–8900. https://doi.org/https://doi.org/10.1073/pnas.1404639111
- Hunter, J. C., Manandhar, A., Carrasco, M. A., Gurbani, D., Gondi, S., & Westover, K. D. (2015). Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations. Molecular Cancer Research: MCR, 13(9), 1325–1335. https://doi.org/https://doi.org/10.1158/1541-7786.MCR-15-0203
- Kamaraj, B., Gopalakrishnan, C., & Purohit, R. (2014). In silico analysis of miRNA-mediated gene regulation in OCA and OA genes. Cell Biochemistry and Biophysics, 70(3), 1923–1932. https://doi.org/https://doi.org/10.1007/s12013-014-0152-9
- Kamaraj, B., & Purohit, R. (2014). Computational screening of disease-associated mutations in OCA2 gene. Cell Biochemistry and Biophysics, 68(1), 97–109. https://doi.org/https://doi.org/10.1007/s12013-013-9697-2
- Kamaraj, B., & Purohit, R. (2016). Mutational Analysis on Membrane Associated Transporter Protein (MATP) and their structural consequences in oculocutaeous albinism Type 4 (OCA4)-a molecular dynamics approach. Journal of Cellular Biochemistry, 117(11), 2608–2619. https://doi.org/https://doi.org/10.1002/jcb.25555
- Kamaraj, B., Rajendran, V., Sethumadhavan, R., Kumar, C. V., & Purohit, R. (2015). Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6. Journal of Biomolecular Structure & Dynamics, 33(4), 834–844. https://doi.org/https://doi.org/10.1080/07391102.2014.915762
- Kamaraj, B., Rajendran, V., Sethumadhavan, R., & Purohit, R. (2013). In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. Journal of Molecular Modeling, 19(12), 5587–5599. https://doi.org/https://doi.org/10.1007/s00894-013-2044-0
- Karachaliou, N., Mayo, C., Costa, C., Magrí, I., Gimenez-Capitan, A., Molina-Vila, M. A., & Rosell, R. (2013). KRAS mutations in lung cancer. Clinical Lung Cancer, 14(3), 205–214. https://doi.org/https://doi.org/10.1016/j.cllc.2012.09.007
- Keskin, O., Tuncbag, N., & Gursoy, A. (2016). Predicting Protein-protein interactions from the molecular to the proteome level. Chemical Reviews, 116(8), 4884–4909. https://doi.org/https://doi.org/10.1021/acs.chemrev.5b00683
- Kumar, A., & Purohit, R. (2014). Use of long term molecular dynamics simulation in predicting cancer associated SNPs. PLoS Computational Biology, 10(4), e1003318 https://doi.org/https://doi.org/10.1371/journal.pcbi.1003318
- Kumar, A., Rajendran, V., Sethumadhavan, R., & Purohit, R. (2013). Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region. PloS One, 8(10), e77453. https://doi.org/https://doi.org/10.1371/journal.pone.0077453
- Kumar, A., Rajendran, V., Sethumadhavan, R., Shukla, P., Tiwari, S., & Purohit, R. (2014). Computational SNP analysis: Current approaches and future prospects. Cell Biochemistry and Biophysics, 68(2), 233–239. https://doi.org/https://doi.org/10.1007/s12013-013-9705-6
- Kumar, D. T., Jain, N., Kumar, S. U., Doss, C. G. P., & Zayed, H. (2019). Identification of potential inhibitors against pathogenic missense mutations of PMM2 using a structure-based virtual screening approach. Journal of Biomolecular Structure and Dynamics, 0(0), 1–17. https://doi.org/https://doi.org/10.1080/07391102.2019.1708797
- Kumar, D. T., Jain, N., Kumar, S. U., Jena, P., Paramita, Ramamoorthy, S., Doss, C. G. P., & Zayed, H. (2020). Molecular dynamics simulations to decipher the structural and functional consequences of pathogenic missense mutations in the galactosylceramidase (GALC) protein causing Krabbe’s disease. Journal of Biomolecular Structure and Dynamics, 0(ja), 1–36. https://doi.org/https://doi.org/10.1080/07391102.2020.1742790
- Kumar S, U., Kumar D, T., R, S., Doss C, G. P., & Zayed, H. (2020). An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia. Computers in Biology and Medicine, 117, 103583. https://doi.org/https://doi.org/10.1016/j.compbiomed.2019.103583
- Kumar, S. U., Kumar, D. T., Siva, R., Doss, C. G. P., & Zayed, H. (2019). Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer. Frontiers in Bioengineering and Biotechnology, 7, 391. https://doi.org/https://doi.org/10.3389/fbioe.2019.00391
- Lee, K. H., Lee, J. S., Suh, C., Kim, S. W., Kim, S. B., Lee, J. H., Lee, M. S., Park, M. Y., Sun, H. S., & Kim, S. H. (1995). Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer, 75(12), 2794–2801. https://doi.org/https://doi.org/10.1002/1097-0142(19950615)75:12 < 2794::aid-cncr2820751203 > 3.0.co;2-f
- Liao, J., Shima, F., Araki, M., Ye, M., Muraoka, S., Sugimoto, T., Kawamura, M., Yamamoto, N., Tamura, A., & Kataoka, T. (2008). Two conformational states of Ras GTPase exhibit differential GTP-binding kinetics. Biochemical and Biophysical Research Communications, 369(2), 327–332. https://doi.org/https://doi.org/10.1016/j.bbrc.2008.01.169
- Lindahl, E. (2015). Molecular Dynamics Simulations. In A. Kukol (Ed.), Molecular modeling of proteins. (pp. 3–26). Springer. https://doi.org/https://doi.org/10.1007/978-1-4939-1465-4_1
- Liu, W. N., Yan, M., & Chan, A. M. (2017). A thirty-year quest for a role of R-Ras in cancer: From an oncogene to a multitasking GTPase. Cancer Letters, 403, 59–65. https://doi.org/https://doi.org/10.1016/j.canlet.2017.06.003
- Lobanov, M. Y., Bogatyreva, N. S., & Galzitskaya, O. V. (2008). Radius of gyration as an indicator of protein structure compactness. Molecular Biology, 42(4), 623–628. https://doi.org/https://doi.org/10.1134/S0026893308040195
- Lowy, D. R., & Willumsen, B. M. (1993). Function and regulation of Ras. Annual Review of Biochemistry, 62(1), 851–891. https://doi.org/https://doi.org/10.1146/annurev.bi.62.070193.004223
- Lu, S., Jang, H., Nussinov, R., & Zhang, J. (2016). The structural basis of oncogenic mutations G12, G13 and Q61 in Small GTPase K-Ras4B. Scientific Reports, 6(1), 21949–21915. https://doi.org/https://doi.org/10.1038/srep21949
- Luscombe, N. M., & Thornton, J. M. (2002). Protein–DNA interactions: Amino Acid conservation and the effects of mutations on binding specificity. Journal of Molecular Biology, 320(5), 991–1009. https://doi.org/https://doi.org/10.1016/S0022-2836(02)00571-5
- Matsuda, K., Shimada, A., Yoshida, N., Ogawa, A., Watanabe, A., Yajima, S., Iizuka, S., Koike, K., Yanai, F., Kawasaki, K., Yanagimachi, M., Kikuchi, A., Ohtsuka, Y., Hidaka, E., Yamauchi, K., Tanaka, M., Yanagisawa, R., Nakazawa, Y., Shiohara, M., … Koike, K. (2007). Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood, 109(12), 5477–5480. https://doi.org/https://doi.org/10.1182/blood-2006-09-046649
- McCormick, F. (1998). Going for the GAP. Current Biology : Cb, 8(19), R673–R675. https://doi.org/https://doi.org/10.1016/S0960-9822(98)70431-2
- McCoy, M. S., Bargmann, C. I., & Weinberg, R. A. (1984). Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. Molecular and Cellular Biology, 4(8), 1577–1582. https://doi.org/https://doi.org/10.1128/mcb.4.8.1577
- Mosaeilhy, A., Mohamed, M. M., C, G. P. D., El Abd, H. S. A., Gamal, R., Zaki, O. K., & Zayed, H. (2017). Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metabolic Brain Disease, 32(5), 1417–1426. https://doi.org/https://doi.org/10.1007/s11011-017-0006-4
- Motojima, K., Urano, T., Nagata, Y., Shiku, H., Tsurifune, T., & Kanematsu, T. (1993). Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Annals of Surgery, 217(2), 138–143.https://doi.org/https://doi.org/10.1097/00000658-199302000-00007
- Muñoz-Maldonado, C., Zimmer, Y., & Medová, M. (2019). A Comparative Analysis of Individual RAS Mutations in Cancer Biology. Frontiers in Oncology, 9, 1088 https://doi.org/https://doi.org/10.3389/fonc.2019.01088
- Nakano, H., Yamamoto, F., Neville, C., Evans, D., Mizuno, T., & Perucho, M. (1984). Isolation of transforming sequences of two human lung carcinomas: Structural and functional analysis of the activated c-K-ras oncogenes. Proceedings of the National Academy of Sciences of the United States of America, 81(1), 71–75. https://doi.org/https://doi.org/10.1073/pnas.81.1.71
- Neal, S. E., Eccleston, J. F., Hall, A., & Webb, M. R. (1988). Kinetic analysis of the hydrolysis of GTP by p21N-ras. The basal GTPase mechanism. The Journal of Biological Chemistry, 263(36), 19718–19722.
- Pace, C. N., Fu, H., Fryar, K. L., Landua, J., Trevino, S. R., Schell, D., Thurlkill, R. L., Imura, S., Scholtz, J. M., Gajiwala, K., Sevcik, J., Urbanikova, L., Myers, J. K., Takano, K., Hebert, E. J., Shirley, B. A., & Grimsley, G. R. (2014). Contribution of hydrogen bonds to protein stability. Protein Science: A Publication of the Protein Society, 23(5), 652–661. https://doi.org/https://doi.org/10.1002/pro.2449
- Parra, R. G., Schafer, N. P., Radusky, L. G., Tsai, M.-Y., Guzovsky, A. B., Wolynes, P. G., & Ferreiro, D. U. (2016). Protein Frustratometer 2: A tool to localize energetic frustration in protein molecules, now with electrostatics. Nucleic Acids Research, 44(W1), W356–360. https://doi.org/https://doi.org/10.1093/nar/gkw304
- Parthiban, V., Gromiha, M. M., & Schomburg, D. (2006). CUPSAT: Prediction of protein stability upon point mutations. Nucleic Acids Research, 34(Web Server issue), W239–242. issue), https://doi.org/https://doi.org/10.1093/nar/gkl190
- Prior, I. A., Lewis, P. D., & Mattos, C. (2012). A comprehensive survey of Ras mutations in cancer. Cancer Research, 72(10), 2457–2467. https://doi.org/https://doi.org/10.1158/0008-5472.CAN-11-2612
- Rahman, K. M. T., Islam, M. F., Banik, R. S., Honi, U., Diba, F. S., Sumi, S. S., Kabir, S. M. T., Akhter, M. S. (2013). Changes in protein interaction networks between normal and cancer conditions: Total chaos or ordered disorder? Network Biology. http://agris.fao.org/agris-search/search.do?recordID=CN2013200002
- Rak, A., Pylypenko, O., Durek, T., Watzke, A., Kushnir, S., Brunsveld, L., Waldmann, H., Goody, R. S., & Alexandrov, K. (2003). Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase. Science (New York, N.Y.).), 302(5645), 646–650. https://doi.org/https://doi.org/10.1126/science.1087761
- Rodrigues, C. H., Pires, D. E., & Ascher, D. B. (2018). DynaMut: Predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Research, 46(W1), W350–W355. https://doi.org/https://doi.org/10.1093/nar/gky300
- Rojas, A. M., Fuentes, G., Rausell, A., & Valencia, A. (2012). The Ras protein superfamily: Evolutionary tree and role of conserved amino acids. The Journal of Cell Biology, 196(2), 189–201. https://doi.org/https://doi.org/10.1083/jcb.201103008
- Román, M., Baraibar, I., López, I., Nadal, E., Rolfo, C., Vicent, S., & Gil-Bazo, I. (2018). KRAS oncogene in non-small cell lung cancer: Clinical perspectives on the treatment of an old target. Molecular Cancer, 17(1), 33. https://doi.org/https://doi.org/10.1186/s12943-018-0789-x
- Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012). Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets, 16(1), 103–119. https://doi.org/https://doi.org/10.1517/14728222.2011.645805
- Santos, E., Martin-Zanca, D., Reddy, E. P., Pierotti, M. A., Della Porta, G., & Barbacid, M. (1984). Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science (New York, N.Y.).), 223(4637), 661–664. https://doi.org/https://doi.org/10.1126/science.6695174
- Sapay, N., & Tieleman, D. P. (2011). Combination of the CHARMM27 force field with united-atom lipid force fields. Journal of Computational Chemistry, 32(7), 1400–1410. https://doi.org/https://doi.org/10.1002/jcc.21726
- Schwede, T., Kopp, J., Guex, N., & Peitsch, M. C. (2003). SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Research, 31(13), 3381–3385. https://doi.org/https://doi.org/10.1093/nar/gkg520
- Seabra, M. C. (1998). Membrane association and targeting of prenylated Ras-like GTPases. Cellular Signalling, 10(3), 167–172. https://doi.org/https://doi.org/10.1016/S0898-6568(97)00120-4
- Shoichet, B. K., Baase, W. A., Kuroki, R., & Matthews, B. W. (1995). A relationship between protein stability and protein function. Proceedings of the National Academy of Sciences of the United States of America, 92(2), 452–456. https://doi.org/https://doi.org/10.1073/pnas.92.2.452
- Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K. V., Gazdar, A. F., … Velculescu, V. E. (2006). The consensus coding sequences of human breast and colorectal cancers. Science (New York, N.Y.).), 314(5797), 268–274. https://doi.org/https://doi.org/10.1126/science.1133427
- Spoerner, M., Herrmann, C., Vetter, I. R., Kalbitzer, H. R., & Wittinghofer, A. (2001). Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proceedings of the National Academy of Sciences of the United States of America, 98(9), 4944–4949. https://doi.org/https://doi.org/10.1073/pnas.081441398
- Studer, R. A., Dessailly, B. H., & Orengo, C. A. (2013). Residue mutations and their impact on protein structure and function: Detecting beneficial and pathogenic changes. The Biochemical Journal, 449(3), 581–594. https://doi.org/https://doi.org/10.1042/BJ20121221
- Tam, I. Y. S., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C. M., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., Gazdar, A. F., & Wong, M. P. (2006). Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clinical Cancer Research, 12(5), 1647–1653. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-05-1981
- Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., Fish, P., Harsha, B., Hathaway, C., Jupe, S. C., Kok, C. Y., Noble, K., Ponting, L., Ramshaw, C. C., Rye, C. E., … Forbes, S. A. (2019). COSMIC: The Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Research, 47(D1), D941–D947. https://doi.org/https://doi.org/10.1093/nar/gky1015
- Thirumal Kumar, D., Jerushah Emerald, L., George Priya Doss, C., Sneha, P., Siva, R., Charles Emmanuel Jebaraj, W., & Zayed, H. (2018). Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2. Metabolic Brain Disease, 33(5), 1699–1710. https://doi.org/https://doi.org/10.1007/s11011-018-0278-3
- Thirumal Kumar, D., Udhaya Kumar, S., Nishaat Laeeque, A. S., Apurva Abhay, S., Bithia, R., Magesh, R., Kumar, M., Zayed, H., & George Priya Doss, C. (2020). Chapter Nine - Computational model to analyze and characterize the functional mutations of NOD2 protein causing inflammatory disorder – Blau syndrome. In R. Donev (Ed.), Advances in protein chemistry and structural biology (Vol. 120, pp. 379–408). Academic Press. https://doi.org/https://doi.org/10.1016/bs.apcsb.2019.11.005
- Udhaya Kumar, S., Priyanka, N., Sneha, P., & George Priya Doss, C. (2015). Functional and structural characterization of missense mutations in PAX6 gene. Frontiers in Biology, 10(4), 377–385. https://doi.org/https://doi.org/10.1007/s11515-015-1346-2
- Udhaya Kumar, S., Thirumal Kumar, D., Bithia, R., Sankar, S., Magesh, R., Sidenna, M., George Priya Doss, C., & Zayed, H. (2020). Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: A systematic and bioinformatics approach. Frontiers in Genetics, 11. https://doi.org/https://doi.org/10.3389/fgene.2020.00734
- U., Kumar, S., Thirumal Kumar, D., Mandal, P. D., Sankar, S., Haldar, R., Kamaraj, B., Walter, C. E. J., Siva, R., George Priya Doss, C., & Zayed, H. (2020). Chapter Eight - Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene. In R. Donev (Ed.), Advances in protein chemistry and structural biology (Vol. 120, pp. 349–377). Academic Press. https://doi.org/https://doi.org/10.1016/bs.apcsb.2019.11.004
- Udhaya Kumar, S., Thirumal Kumar, D., Siva, R., George Priya Doss, C., Younes, S., Younes, N., Sidenna, M., & Zayed, H. (2020). Dysregulation of signaling pathways due to differentially expressed genes from the B-Cell transcriptomes of systemic lupus erythematosus patients - A bioinformatics approach. Frontiers in Bioengineering and Biotechnology, 8, 276 https://doi.org/https://doi.org/10.3389/fbioe.2020.00276
- UniProt Consortium. (2019). UniProt: A worldwide hub of protein knowledge. Nucleic Acids Research, 47(D1), D506–D515. https://doi.org/https://doi.org/10.1093/nar/gky1049
- UniProt Consortium. (2018). UniProt: The universal protein knowledgebase. Nucleic Acids Res, 46(5), 2699–2699.https://doi.org/https://doi.org/10.1093/nar/gky092
- Vetter, I. R., & Wittinghofer, A. (2001). The guanine nucleotide-binding switch in three dimensions. Science (New York, N.Y.).), 294(5545), 1299–1304. https://doi.org/https://doi.org/10.1126/science.1062023
- Weinberg, R. A. (1982). Fewer and fewer oncogenes. Cell, 30(1), 3–4. https://doi.org/https://doi.org/10.1016/0092-8674(82)90003-4
- Welsch, M. E., Kaplan, A., Chambers, J. M., Stokes, M. E., Bos, P. H., Zask, A., Zhang, Y., Sanchez-Martin, M., Badgley, M. A., Huang, C. S., Tran, T. H., Akkiraju, H., Brown, L. M., Nandakumar, R., Cremers, S., Yang, W. S., Tong, L., Olive, K. P., Ferrando, A., & Stockwell, B. R. (2017). Multivalent small-molecule Pan-RAS inhibitors. Cell, 168(5), 878–889.e29. https://doi.org/https://doi.org/10.1016/j.cell.2017.02.006
- Xu, K., Park, D., Magis, A. T., Zhang, J., Zhou, W., Sica, G. L., Ramalingam, S. S., Curran, W. J., & Deng, X. (2019). Small molecule KRAS agonist for mutant KRAS cancer therapy. Molecular Cancer, 18(1), 85.https://doi.org/https://doi.org/10.1186/s12943-019-1012-4
- Xu, S., Long, B. N., Boris, G. H., Chen, A., Ni, S., & Kennedy, M. A. (2017). Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras. Acta Crystallographica. Section D, Structural Biology, 73(Pt 12), 970–984. https://doi.org/https://doi.org/10.1107/S2059798317015418
- Yang, H., Liang, S.-Q., Schmid, R. A., & Peng, R.-W. (2019). New horizons in KRAS-mutant lung cancer: Dawn after darkness. Frontiers in Oncology, 9, 953 https://doi.org/https://doi.org/10.3389/fonc.2019.00953
- Yun, S., & Guy, H. R. (2011). Stability tests on known and misfolded structures with discrete and all atom molecular dynamics simulations. Journal of Molecular Graphics & Modelling, 29(5), 663–675. https://doi.org/https://doi.org/10.1016/j.jmgm.2010.12.002
- Zaki, O. K., Krishnamoorthy, N., El Abd, H. S., Harche, S. A., Mattar, R. A., Al Disi, R. S., Nofal, M. Y., El Bekay, R., Ahmed, K. A., George Priya Doss, C., & Zayed, H. (2017). Two patients with Canavan disease and structural modeling of a novel mutation. Metabolic Brain Disease, 32(1), 171–177. https://doi.org/https://doi.org/10.1007/s11011-016-9896-9
- Zaki, O. K., Priya Doss C, G., Ali, S. A., Murad, G. G., Elashi, S. A., Ebnou, M. S. A., Kumar D, T., Khalifa, O., Gamal, R., El Abd, H. S. A., Nasr, B. N., & Zayed, H. (2017). Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants. Human Molecular Genetics, 26(16), 3105–3115. https://doi.org/https://doi.org/10.1093/hmg/ddx195
- Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011). SwissParam: A fast force field generation tool for small organic molecules. Journal of Computational Chemistry, 32(11), 2359–2368. https://doi.org/https://doi.org/10.1002/jcc.21816